Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003508 |
---|---|
Receipt number | R000004250 |
Scientific Title | Phase I/II clinical study of WT1 peptide-based immunotherapy combined with Imatinib for chronic myelogeneous leukemia |
Date of disclosure of the study information | 2010/04/19 |
Last modified on | 2014/11/27 15:39:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/04/19 22:04:05 | ||
2 | Update | 2010/06/21 17:59:33 | Public title |
|
3 | Update | 2010/06/21 17:59:55 | Condition |
|
4 | Update | 2011/06/09 13:55:11 | Name of person sending information Organization Division name Address |
|
5 | Update | 2014/11/27 15:37:47 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2014/11/27 15:39:00 | Interventions/Control_1 |
|
7 | Update | 2014/11/27 15:39:37 | Recruitment status Last follow-up date |